Year
Edition number
№6 / 2026
ORIGINAL STUDIES
L.L. Sarkisyan, S.V. Kruchinova, E.D. Kosmacheva
Influence of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes during lung cancer chemotherapy9-17
I.V. Petrenko, O.M. Reitblat, D.R. Bulatova, A.V. Khristolyubova
Analysis of the efficacy of alirocumab genetically engineered therapy in patients with very high cardiovascular risk, with and without diabetes mellitus: A prospective registry study18-27
A.A. Abramov, T.M. Timofeeva, V.V. Tolkacheva, I.S. Nazarov, Zh.D. Kobalava
Comparative conformity of Russian and international criteria for identifying pre-stages of heart failure in coronary artery disease patients: A cross cohort study28-40
V.A. Safronenko, A.I. Chesnikova, T.V. Tayutina, N.D. Bogunova
A prognostic model of adverse cardiovascular events in patients with chronic heart failure depending on the presence of frailty syndrome42-49
M.V. Gorkin, U.M. Shadrina, M.A. Korzhova, E.A. Guryanova, V.I. Dzhum, L.B. Mitrofanova, O.B. Irtyuga
Risk groups for latent infective endocarditis in patients with aortic stenosis50-58
V.P. Mikhin, L.S. Maltseva, N.L. Kostina, T.A. Nikolenko, G.V. Panchenko, K.A. Elagina
Prevalence of elevated lipoprotein(a) level in the blood of patients with acute coronary syndrome living in the regional center of the Central Black Earth Region59-69
O.P. Shevchenko, S.O. Sharapchenko, DA. Velikiy, O.E. Gichkun Ersin, N.P. Mozheiko, A.O. Shevchenko, S.V. Gautier
MicroRNA in heart failure and acute transplanted heart rejection: Diagnostic and prognostic value of miR-10170-82
N.I. Khutsishvili, I.S. Nazarov, A.F. Safarova, V.V. Tolkacheva, A.A. Abramov, Zh.D. Kobalava
Assessment of heart stress by age-dependent NT-proBNP thresholds for early diagnosis and prediction of cardiovascular outcomes in patients with type 2 diabetes mellitus83-92
N.V. Korneeva, A.N. Gryazev, N.N. Mislimova
The time of day of primary percutaneous coronary intervention as an independent risk factor for long-term mortality and a prognosis modifier effect in patients with ST-segment elevation acute coronary syndrome: A case study at the Sakhalin Regional Clinical Hospital93-102
D.A. Vyzhigin, Yu.A. Vasyuk, E.Yu. Shupenina, E.O. Novosel, L.G. Zhukova, D.A. Filonenko, D.A. Astakhov, A.S. Dorofeev
Heart rhythm and conduction impairments in cancer patients: Clinical and functional peculiarities103-114
I.A. Zolotovskaya, D.V. Duplyakov, P.R. Shatskaia
Artificial intelligence as a “co-pilot” in phenotyping patients with arterial hypertension and chronic cerebral ischemia115-124
REVIEWS
Kh.R. Dovlatukaeva, R.A. ogly Faradzhov, Yu.M. Yufereva, A.O. Shevchenko
Clinical efficacy of proactive motivational counseling in patients who underwent acute coronary syndrome126-134
N.Yu. Borovkova, A.T. Egorskaia, A.S. Tokareva, V.K. Kurashin, N.A. Troshina, M.A. Mironov
High-sensitive C-reactive protein as a cardiovascular risk marker135-143
O.G. Musaev, V.I. Vechorko, A.O. Shevchenko, K.B. Lebedeva, N.V. Viktorov
Enhanced recovery after cardiac surgery: ERACS concept, the role of the therapist, and local intervention144-152
K.N. Tkachenko, M.S. Tyuryupov, P.G. Shakhnovich, D.V. Cherkashin, K.V. Matyushenko, D.S. Bogdanov
Current possibilities for assessing and correcting the structural and functional condition of the diaphragm in patients with chronic heart failure153-160
GUIDELINES FOR PRACTITIONERS
S.D. Mayanskaya, A.A. Gilmanov, E.I. Safina, K.N. Ermakova, S. A. Fayzrakhmanova, A.S. Mironova, M.M. Mangusheva
Peripartum cardiomyopathy with high arrhythmogenic activity: A clinical case162-169
LECTURE
S.V. Gautier, A.O. Shevchenko
Drug therapy in heart transplant recipients170-177
Guideline for practitioners
E.A. Shestakova, E.V. Vechorko
Potential of hypoglycemic therapy to reduce the risk of recurrent cardiovascular events in individuals without diabetes mellitus178-182
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT
N.Yu. Grigorieva, A.D. Postnikova
Selecting rational antihypertensive therapy in patients with arterial hypertension and gastroesophageal reflux disease184-196
